Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data and UPitt Cancer Institute Collaborate on Metabolomics Analysis

NEW YORK, Jan. 12 (GenomeWeb News) - Clinical Data will collaborate with the University of Pittsburgh Cancer Institute on a metabolomics study of lung cancer patients, the company said today.


Under the agreement, Clinical Data will apply metabolomics analysis to serum samples from a population of patients diagnosed with lung cancer and matched controls without lung cancer. UPCI will provide the serum samples.


Any new intellectual property or inventions from this study will remain the property of the discovering party, Clinical Data said. Both parties retain the rights to publish the results and disseminate information pertaining to the research conducted under the agreement.


The study is part of the National Caner Institute's Specialized Program of Research Excellence in Lung Cancer at UPCI.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.